Compare · CMD vs MDLN
CMD vs MDLN
Side-by-side comparison of Cantel Medical Corp. (CMD) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CMD and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN carries a market cap of $48.08B.
- MDLN has hit the wire 7 times in the past 4 weeks while CMD has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 0 for CMD).
- Company
- Cantel Medical Corp.
- Medline Inc.
- Price
- -
- -
- Market cap
- -
- $48.08B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- n/a
- 2025
- News (4w)
- 0
- 7
- Recent ratings
- 0
- 25
Latest CMD
- Sanitizing Agents Market Poised for over 7.8% Growth by 2029, Growing by Increasing Investment in The Development of Eco-Friendly Acid-Based Chemicals: States by Exactitude Consultancy
- SEC Form SC TO-I/A filed by Cantel Medical Corp. (Amendment)
- SEC Form SC TO-I/A filed by Cantel Medical Corp. (Amendment)
- SEC Form 15-12B filed by Cantel Medical Corp.
- SEC Form SC 13G filed by Cantel Medical Corp.
- SEC Form 8-K filed by Cantel Medical Corp.
- SEC Form SC TO-I filed by Cantel Medical Corp.
- SEC Form 4 filed by Cantel Medical Corp.
- SEC Form 4 filed by Cantel Medical Corp.
- SEC Form 4 filed by Cantel Medical Corp.
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M